Chemotherapy-Induced Peripheral Neuropathy: What It Feels Like, Whether It Goes Away, and What May Help

Peripheral nerves carry information between the brain and spinal cord and the rest of the body. Some chemotherapy drugs can damage these nerves, particularly the long sensory nerves that reach the hands and feet. 

Chemotherapy-induced peripheral neuropathy (CIPN) can begin as slight tingling, numbness, or an unusual sensitivity to cold. Some people describe having trouble fastening buttons, holding a coffee cup, walking safely, or feeling the ground beneath them. Others find that the pain interferes with sleep or keeps them from exercising, cooking, gardening, working, or playing with their grandchildren. CIPN can eventually progress to burning, stabbing, or electric-shock level of pain. 

“Like you have hot embers inside your hands and feet,” describes master herbalist Trevor Clark, who recently joined the Heal Navigator podcast to discuss CIPN. Clark’s own neuropathy began not during chemo, but after spinal surgery he had as a young man. His experience eventually led him to study herbal sciences and begin work with people managing several forms of neuropathy. 

A 2026 global review found that 52%, of e patients reporting persistent, moderate-to-severe neuropathy symptoms or pain. 

The intensity of the nerve damage can depend on the drug, the cumulative dose, the treatment schedule, and individual factors such as age, diabetes, preexisting neuropathy, and previous exposure to neurotoxic chemotherapy

What Does Chemo Neuropathy Feel Like?

CIPN often begins symmetrically in the hands and feet in what experts describe as a “stocking-and-glove” pattern. Early symptoms may include:

• Tingling or pins and needles
• Numbness or reduced sensation
• Unusual sensitivity to touch
• Burning, shooting, or electric pain
• Cold sensitivity
• Cramping or muscle weakness
• Problems with balance or coordination
• Difficulty with fine-motor tasks such as writing, typing, buttoning clothes, or opening jars

These symptoms are not always painful right away. But numbness alone can still be dangerous because a person may not feel a burn, cut, blister, or uneven surface. Motor-nerve damage can contribute to weakness and falls, while autonomic-nerve damage can sometimes affect digestion, blood pressure, sweating, or urination. 

During the podcast, Clark also emphasized that sometimes a patient may experience symptoms that do not necessarily register on clinical symptom scales, but are no less debilitating: the golfer who can no longer grip his club, the gardener who cannot use her hands comfortably, a grandparent who no longer feels steady enough to play with her grandchildren. 

These experiences should not be minimized. According to Clark, evaluating neuropathy only by how much it hurts is a mistake. Patients and their care teams also need to consider the loss of function – and the parts of daily life that neuropathy has taken away.

Which Chemo Drugs Cause Peripheral Neuropathy?

Several classes of chemotherapy and other cancer drugs are associated with peripheral neuropathy, including:

• Taxanes, including paclitaxel and docetaxel
• Platinum drugs, particularly oxaliplatin and cisplatin
• Vinca alkaloids, including vincristine and vinblastine
• Proteasome inhibitors, such as bortezomib
• Immunomodulatory drugs, including thalidomide

Clark explained, these drugs do not all damage nerves in the same way. Taxanes and vinca alkaloids interfere with microtubules, structures involved in both cell division and transport within nerve cells. 

Platinum drugs can damage neuronal DNA and other cellular structures. These differences help explain why one drug may produce pronounced cold sensitivity while another causes numbness, burning, or weakness.

Not everyone taking one of these drugs will develop neuropathy, and experiencing symptoms does not automatically mean chemotherapy must stop. However, patients should communicate symptoms as early as possible. Waiting until the next appointment may reduce the opportunity to make early adjustments that could help protect nerve function.

Will Chemo Neuropathy Go Away without Treatment?

Sometimes, but recovery is highly individual.

Some patients notice substantial improvement within weeks or months after chemotherapy ends. For others, numbness or pain may persist for years. 

Approximately 30% of patients still reported neuropathy at least six months after chemotherapy. A large breast-cancer study also found that more than 40% of participants treated with taxanes still reported numbness or tingling two years later.

Recovery depends on factors; including the drug involved, cumulative exposure, symptom severity, preexisting nerve health, and whether treatment can be modified. Nerves can recover slowly, so progress may be measured in months rather than days. Pain and burning may improve before sensation fully returns.

There is no guarantee that chemotherapy nerve damage will be repaired or that symptoms will disappear. But “It may go away, it may not,” does not have to be the beginning and end of the conversation. As Clark suggested, persistent symptoms can still be assessed and managed, and physical or occupational therapy may help patients maintain function while the nerves recover.

What Can You Do If You Develop Chemo Neuropathy

Can Supplements or Botanical Support Help? 

Patients searching online for a natural treatment for neuropathy in the feet – or asking what natural remedy helps neuropathy – will find no shortage of supplement protocols. But when they go to their Oncologists to 

This is Clark’s speciality. His interest in supplements and natural medicine begin with his own experience with neuropathy. After a serious car accident left him with severe neuropathy and fibromyalgia that conventional medications did little to relieve, he discovered an herb that dramatically improved his fibromyalgia symptoms. Eventually this led him to pursue formal training in herbal science.

Clark’s approach is not to give every patient the same list of supplements. He begins by looking at the chemotherapy drug involved, when the symptoms started, the type and severity of those symptoms, and the patient’s medications and existing supplements. From there, he may recommend nutritional or botanical support intended to address inflammation, nutritional depletion, circulation, or the cellular environment surrounding the nerves.

Integrating Supplements Safely During Chemotherapy

Clark repeatedly emphasized that botanical support should be coordinated with the patient’s oncology team. Herbs and supplements can affect bleeding, liver function, drug metabolism, or the way other medications work. Patients taking blood thinners require particular caution.

And while timing is certainly an important factor, there is no universal rule that makes a supplement safe simply because it is stopped on the day of an infusion. The specific product, dose, chemotherapy regimen, other medications, and patient’s health all need to be considered.

Patients should bring their complete supplement list – and ideally the product bottles or labels – to an oncologist or oncology pharmacist. They should also be wary of protocols generated online or through AI that do not account for their diagnosis, treatment regimen, laboratory results, and possible interactions.

As Clark noted, patients may arrive at his office taking 20 supplements without remembering why they started each one. His goal is to use only what is necessary, monitor whether it is helping, and adjust or discontinue it when it is no longer needed.

Medication 

Duloxetine is currently the only medication with sufficient evidence for ASCO to recommend it for established, painful CIPN. In one clinical trial, patients receiving duloxetine experienced a greater reduction in average pain than those receiving the placebo. 

Gabapentin is frequently prescribed for nerve pain, but evidence for gabapentin in chemotherapy-induced peripheral neuropathy is limited. 

That does not mean an individual patient can never benefit from gabapentin or another medication. Anyone considering medication should speak with their oncologist about what improvements they can expect, how long they should try it, and how side effects such as dizziness or sedation will be monitored.

Exercise

Among non-drug approaches, exercise has a favorable overall risk-benefit profile when it is adapted to the patient. Studies suggest potential improvements in symptoms, balance, strength, and quality of life, but the ideal program and its ability to prevent nerve damage are still being defined.

For someone whose feet are numb or painful, “exercise more” is not a sufficient plan. The first step may be supervised balance work, seated strength training, water exercise, or short walks with an assistive device.

Acupuncture

Recent studies have reported improvements in some CIPN symptoms through the use of acupuncture. 

Patients interested in acupuncture for cancer should seek a licensed practitioner experienced in oncology care. Low platelets, infection risk, lymphedema precautions, anticoagulants, and skin changes may affect whether and how it can be performed safely.

Scrambler therapy and other forms of neuromodulation

Scrambler therapy sends electrical signals through electrodes placed on the skin with the goal of changing how the brain interprets pain. Other approaches include transcutaneous electrical nerve stimulation and related forms of neuromodulation. The field is still in its early stages of research, though a 2022 systematic review shows promising evidence has begun to emerge. 

Physical and occupational therapy

Physical therapy can address gait, balance, strength, and fall prevention. Occupational therapy can help patients adapt tasks involving grip and fine-motor control. A therapist may also recommend assistive devices or home modifications before a fall or injury occurs.

Practical protection for numb hands and feet

When sensation is reduced:

• Check hands and feet daily for cuts, blisters, burns, or swelling.
• Wear supportive shoes and avoid walking barefoot.
• Test bath or dishwater with an unaffected body part or a thermometer.
• Use gloves for cooking, cleaning, and gardening.
• Improve lighting and remove loose rugs or other trip hazards.
• Use handrails and ask for a fall-risk assessment if balance changes.

Is it Possible to Prevent Chemotherapy Induced Peripheral Neuropathy?

According to Clark, preventing CIPN before beginning chemotherapy can be a double-edged sword. “It’s so much easier to prevent or even catch it early when the first signs start to appear,” Clark said. “It just gets harder and harder as the nerve damage gets more entrenched.”

“But,” he continued, “after the initial diagnosis, the last thing most people are thinking about is addressing neuropathy because they really don’t have a frame of reference for it and because they are managing so many other things.”

Still, there are several steps one can take before undergoing treatment:

Establish a baseline

Tell your oncologist if you already have numbness, tingling, diabetes, balance problems, prior nerve damage, or difficulty with fine-motor tasks. A baseline makes it easier to identify meaningful changes during treatment.

Report symptoms early

Do not wait for tingling to become painful or for numbness to interfere with walking. Your oncology team may perform a neurologic assessment, check for other causes, adjust the infusion rate or schedule, reduce a dose, delay treatment, or consider a substitution.

Cooling Gloves and Socks During Chemotherapy

One preventive strategy Clark discussed is cryotherapy, in which patients wear cold gloves and socks during chemotherapy infusions. Cooling the hands and feet temporarily reduces blood flow to the extremities, which may limit the amount of a neurotoxic chemotherapy drug reaching the peripheral nerves.

The evidence is becoming more encouraging. A 2025 clinical trial found that both cooling and compression reduced the risk of moderate-to-severe neuropathy in patients receiving taxane chemotherapy.

However, cooling is not appropriate for every patient or chemotherapy regimen. Oxaliplatin, for example, can cause acute cold sensitivity, and improperly used frozen gloves or socks can damage the skin. Patients should ask whether their infusion center offers or recommends cooling rather than attempting it without medical guidance.

Exercise and Nutrition

Clark also encourages patients to remain as active as they safely can. Exercise may improve circulation, balance, strength, and quality of life, although it becomes more difficult as neuropathy progresses.

A 2024 systematic review found that exercise may improve CIPN symptoms and quality of life, but researchers still do not know which type, duration, or intensity works best. For someone already experiencing numbness, weakness, or balance problems, “exercise more” is not enough of a plan. A physical therapist or cancer exercise specialist can help adapt movement to the patient’s abilities and fall risk.

Clark also recommends an anti-inflammatory eating pattern, such as the Mediterranean or Keto diet, with an emphasis on nutrient-dense foods and sources of omega-3 fatty acids. While this may support overall health during treatment, there is not enough evidence to say that any particular diet can prevent or reverse chemotherapy-related nerve damage.

Questions to Ask Your Oncology Team

Before or during treatment with a neurotoxic chemotherapy drug, consider asking:

• Is peripheral neuropathy common with my specific drug and dose?
• What symptoms should I report immediately?
• How will you assess my nerve function during treatment?
• Does your center offer cooling or compression, and is it appropriate for my regimen?
• If symptoms begin, what treatment changes might we consider?
• Would duloxetine be appropriate if I develop painful neuropathy?
• Can you refer me to physical therapy, occupational therapy, rehabilitation, pain management, or integrative oncology?
• Who can review my supplements for interactions with my cancer treatment?

Treatment for CIPN will depend on whether the primary problem is pain, numbness, weakness, balance, or loss of function. Often, patients need more than one form of support.

The care team should consider both the expected benefit of continuing the current regimen and the effect neuropathy is having on the patient’s safety, function, and quality of life.What can I do now to reduce fall and injury risk?

The Bottom Line

Chemotherapy-induced peripheral neuropathy can affect far more than physical comfort. It can profoundly affect independence, quality of life and, in some cases, cancer treatment itself. The good news is that early recognition, open communication with your oncology team, and the right supportive care may make a meaningful difference, whether you’re preparing to begin chemotherapy, currently receiving it, or living with lingering symptoms months after completing treatment..